Can erythropoietin be used to prevent brain damage in cerebral malaria?
Erythropoietin (Epo) modulates the survival of developing erythroid cells and the production of new erythrocytes in the bone marrow and is a key molecule in the adaptation to hypoxia and anaemia. Epo receptors have been found to be widely expressed on non-haematopoietic cells, and Epo has been shown...
المؤلفون الرئيسيون: | Casals-Pascual, C, Idro, R, Picot, S, Roberts, D, Newton, C |
---|---|
التنسيق: | Journal article |
اللغة: | English |
منشور في: |
2009
|
مواد مشابهة
-
Erythropoietin and neuro-protection in African children with cerebral malaria
حسب: Idro, R, وآخرون
منشور في: (2008) -
High levels of erythropoietin are associated with protection against neurological sequelae in African children with cerebral malaria.
حسب: Casals-Pascual, C, وآخرون
منشور في: (2008) -
Cerebral malaria: mechanisms of brain injury and strategies for improved neurocognitive outcome.
حسب: Idro, R, وآخرون
منشور في: (2010) -
Pathogenesis, clinical features, and neurological outcome of cerebral malaria.
حسب: Idro, R, وآخرون
منشور في: (2005) -
A better biomarker for cerebral malaria: in the eye of the beheld?*.
حسب: Ackerman, H, وآخرون
منشور في: (2012)